A pharmacogenomics standard for FDA drug approval: Arbitrary and capricious or safe and effective?

被引：1

|

作者：

Wu, DJ ^{[1
]}

机构：

[1] Calif Western Sch Law, San Diego, CA USA

来源：

BIOTECHNOLOGY LAW REPORT | 2004年 / 23卷 / 06期

关键词：

D O I：

10.1089/blr.2004.23.733

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

收藏

页码：733 / 746

页数：14

相关论文

共 50 条

[1] FDA and drug approval
Faich, GA
[J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 1995, 6 (06) : S24 - S24
[2] FDA AND DRUG APPROVAL PROCESS
KENNEDY, D
[J]. CONNECTICUT MEDICINE, 1978, 42 (10) : 651 - 656
[3] A lupus drug and FDA approval
Merrill, JT
Raymond, S
[J]. SCIENCE, 2005, 308 (5721) : 497 - 497
[4] DRUG APPROVAL PROCESS AND FDA
SCHMIDT, AM
[J]. NEW YORK STATE JOURNAL OF MEDICINE, 1976, 76 (12) : 2039 - 2042
[5] Will FDA relinquish the "gold standard" for new drug approval? Redefining "substantial evidence" in the FDA modernization act of 1997
Kulynych, J
[J]. FOOD AND DRUG LAW JOURNAL, 1999, 54 (01) : 127 - 149
[6] FDA provides fastest drug approval
Gilbert, Judith A.
[J]. LANCET ONCOLOGY, 2012, 13 (07): : E287 - E287
[7] THE FDA AND PRIVATIZATION - THE DRUG APPROVAL PROCESS
RUTHERFORD, EM
[J]. FOOD AND DRUG LAW JOURNAL, 1995, : 203 - 225
[8] LUPUS DRUG NEARS FDA APPROVAL
不详
[J]. CHEMICAL & ENGINEERING NEWS, 2010, 88 (47) : 17 - 17
[9] FDA drug approval summaries: Oxaliplatin
Ibrahim, A
Hirschfeld, S
Cohen, MH
Griebel, DJ
Williams, GA
Pazdur, R
[J]. ONCOLOGIST, 2004, 9 (01): : 8 - 12
[10] What makes consumers think dietary supplements are safe and effective? The role of disclaimers and FDA approval
Dodge, Tonya
Kaufman, Annette
[J]. HEALTH PSYCHOLOGY, 2007, 26 (04) : 513 - 517

← 1 2 3 4 5 →